Former heavyweight champion Joseph Parker has insisted that a positive drug test, which led to his temporary suspension from boxing, was the result of exposure to cocaine used by his personal nutritionist, according to a statement from UK Anti-Doping (UKAD). The New Zealander tested positive for benzoylecgonine, a metabolite that indicates cocaine consumption, after a routine UKAD screening that took place shortly after his unexpected loss to Fabio Wardley in London on 25 October 2025. Parker has consistently denied ever taking a prohibited substance and, on Wednesday, announced that the provisional ban – which could have stretched to two years – had been lifted, allowing him to return to the ring "soon". The following day, UKAD confirmed that Parker was free to resume his boxing career and released details of the investigation, including the 34‑year‑old's explanation for the adverse analytical finding (AAF).
In a formal UKAD press release the agency noted that on 6 March 2026 Parker supplied evidence claiming the AAF stemmed from his exposure to cocaine used by the nutritionist he had hired in preparation for the October 2025 bout. The nutritionist reportedly admitted to being a regular cocaine user and said he had taken the drug daily during the week leading up to the fight.
UKAD later requested additional information from Parker between 14 April and 3 June 2026, during which time Parker clarified that he had first begun working with the same nutritionist in April 2023. After reviewing the case, UKAD decided to impose a three‑month period of ineligibility, which it considered already served, because an independent scientific expert concluded that any cocaine ingestion occurred out of competition – that is, before 11:59 p.m. on 24 October 2025 – and therefore had no bearing on Parker's sporting performance.
The expert’s opinion, received by UKAD on 15 June 2026, suggested that the cocaine exposure most likely happened outside the competitive window and was unrelated to Parker’s preparation for the fight. Consequently, UKAD lifted Parker's provisional suspension on 22 June 2026, allowing him to compete immediately, while still recording a three‑month sanction as a formal penalty for the anti‑doping rule violation. The scientific consultant also entertained the possibility that the cocaine could have entered Parker’s system via contaminated food, stating that the nutritionist’s admitted cocaine use might have tainted meals prepared for the athlete.
However, the expert could not rule out that the benzoylecgonine detected in Parker’s urine might represent the tail‑end of a larger, pharmacologically active dose of cocaine. In other words, while contamination was plausible, the evidence was not sufficient to exclude a more direct ingestion scenario. As a result of the anti‑doping findings, the outcome of Parker’s fight with Wardley – originally recorded as an 11th‑round stoppage loss for Parker – has been altered to a defeat by disqualification rather than a knockout. The decision underscores how doping violations can retroactively affect match results, even when the athlete claims inadvertent exposure.
Parker’s career trajectory provides context for the significance of this controversy. He first captured a world title in 2018, losing it to Anthony Joshua later that year. After a tough defeat to Joe Joyce in 2022, Parker rebounded impressively, winning six consecutive fights, including high‑profile victories over former champion Deontay Wilder and heavyweight contender Zhilei Zhang, and securing the WBO interim belt. He was slated to challenge IBF champion Daniel Dubois in February 2026, but Dubois withdrew due to illness just days before the scheduled bout.
Undeterred, Parker risked his mandatory challenger status for undisputed champion Oleksandr Usyk by taking the fight against Wardley, a gamble that ultimately backfired. The broader implications of Parker’s case extend beyond his personal narrative.
It highlights the complexities of anti‑doping enforcement in combat sports, where athletes often rely on a support team—including trainers, doctors, and nutritionists—who may inadvertently introduce prohibited substances. UKAD’s decision to treat the violation as out‑of‑competition reflects a nuanced approach that balances strict liability with scientific evidence, acknowledging that not all positive tests stem from intentional cheating. Looking ahead, Parker has indicated his intention to return to competition as soon as possible.
With his provisional suspension lifted, he can now focus on rebuilding his ranking and pursuing another shot at a world title. The episode may also prompt athletes and their support staff to adopt stricter protocols regarding substance use, food handling, and overall compliance with anti‑doping regulations, reducing the risk of accidental contamination in the future. In summary, Joseph Parker’s positive test for a cocaine metabolite has been re‑characterized as a non‑sport‑performance‑related incident, leading to a brief sanction that is considered served.
The case underscores the importance of thorough scientific investigation in anti‑doping proceedings and serves as a cautionary tale for athletes who depend heavily on external personnel for nutrition and training support.